See All News - tctmd.com

News

News Daily News

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Todd Neale

October 26, 2015

News Industry News

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure

October 22, 2015

News Industry News

Medtronic Receives CE Mark for New Single-Chamber ICDs That Can Detect Atrial Fibrillation

October 21, 2015

News Daily News

Turning Fellows to Flowers: John S. Douglas, Jr., Transforms Trainees at One of the Longest-Running Interventional Fellowship Programs

Yael L. Maxwell

October 20, 2015

News Industry News

Bolton Medical Announces the First Patient Treated with the New TREO® Abdominal Stent-Graft System

October 20, 2015

News Industry News

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

October 20, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

News Industry News

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

October 16, 2015

Advertisement

News

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure

Medtronic Receives CE Mark for New Single-Chamber ICDs That Can Detect Atrial Fibrillation

Turning Fellows to Flowers: John S. Douglas, Jr., Transforms Trainees at One of the Longest-Running Interventional Fellowship Programs

Bolton Medical Announces the First Patient Treated with the New TREO® Abdominal Stent-Graft System

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

My Takeaways From TCT 2015

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content